ESTYBON
associated with 13 other trademarks
pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematolog...

Words that describe this trademark:

drugs treatment  treatment cancer  myelodysplastic syndromes  pharmaceuticals drugs  cancer pancreatic  ovarian cancer  pancreatic cancers  cancers  cancer  syndromes 

Serial Number:

77833465

Mark:

ESTYBON

Status:

Cancelled-Section 8

Status Date:

05-28-2021

Filing Date:

Registration Number:

3868532

Registration Date:

10-26-2010

Goods and Services:

pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

04-20-2010

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

BARTON LLP

Correspondent Name:

Recent Trademark filings by this company